Skip to main content
Log in

Drawbacks of Artificial Intelligence and Their Potential Solutions in the Healthcare Sector

  • Review
  • Published:
Biomedical Materials & Devices Aims and scope Submit manuscript

Abstract

Artificial intelligence (AI) has the potential to make substantial progress toward the goal of making healthcare more personalized, predictive, preventative, and interactive. We believe AI will continue its present path and ultimately become a mature and effective tool for the healthcare sector. Besides this AI-based systems raise concerns regarding data security and privacy. Because health records are important and vulnerable, hackers often target them during data breaches. The absence of standard guidelines for the moral use of AI and ML in healthcare has only served to worsen the situation. There is debate about how far artificial intelligence (AI) may be utilized ethically in healthcare settings since there are no universal guidelines for its use. Therefore, maintaining the confidentiality of medical records is crucial. This study enlightens the possible drawbacks of AI in the implementation of healthcare sector and their solutions to overcome these situations.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+
from $39.99 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data Availability

All data are provided with in the paper.

Abbreviations

AI:

Artificial intelligence

ML:

Machine learning

DL:

Data learning

HIV:

Human immunodeficiency syndrome

SARS:

Severe acute respiratory syndrome

NHS:

National Health Service

FDA:

Food and Drug Administration

References

  1. H.C.S. Chan, H. Shan, T. Dahoun, H. Vogel, S. Yuan, Advancing drug discovery via artificial intelligence. Trends Pharmacol. Sci. 40(8), 592–604 (2019)

    Article  CAS  Google Scholar 

  2. O. Cruciger, T.A. Schildhauer, R.C. Meindl, M. Tegenthoff, P. Schwenkreis, M. Citak, M. Aach, Impact of locomotion training with a neurologic controlled hybrid assistive limb (HAL) exoskeleton on neuropathic pain and health related quality of life (HRQoL) in chronic SCI: a case study. Disabil. Rehabil. Assist. Technol. 11(6), 529–534 (2016)

    Google Scholar 

  3. Ó. Díaz, J.A.R. Dalton, J. Giraldo, Artificial intelligence: a novel approach for drug discovery. Trends Pharmacol. Sci. 40(8), 550–551 (2019)

    Article  Google Scholar 

  4. J. Habermann, Psychological impacts of COVID-19 and preventive strategies: A review. (2021).

  5. S. Harrer, P. Shah, B. Antony, J. Hu, Artificial intelligence for clinical trial design. Trends Pharmacol. Sci. 40(8), 577–591 (2019)

    Article  CAS  Google Scholar 

  6. A. Holzinger, C. Biemann, C. S. Pattichis, D. B. Kell, What do we need to build explainable AI systems for the medical domain? (2017). https://arXiv.Org/:1712.09923.

  7. P. Hummel, M. Braun, Just data? Solidarity and justice in data-driven medicine. Life Sci., Soc. Policy 16(1), 1–18 (2020)

    Article  Google Scholar 

  8. U. Schmidt-Erfurth, H. Bogunovic, A. Sadeghipour et al., Machine learning to analyze the prognostic value of current imaging biomarkers in neovascular age-related macular degeneration. Opthamol. Retina 2, 24–30 (2018)

    Article  Google Scholar 

  9. S.I. Lee, S. Celik, B.A. Logsdon et al., A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia. Nat. Commun. 9, 42 (2018)

    Article  Google Scholar 

  10. M. Sordo, Introduction to neural networks in healthcare. OpenClin. (2002).

  11. S. Ji, Q. Gu, H. Weng, Q. Liu, P. Zhou, Q. He, R. Beyah, T. Wang, De-health: all your online health information are belong to us. arXiv preprint. (2019).

  12. B. Lubarsky, Re-identification of “anonymized data.” UCLA L. Rev. 1701, 1754 (2010)

    Google Scholar 

  13. M.K. Baowaly, C.C. Lin, C.L. Liu, K.T. Chen, Synthesizing electronic health records using improved generative adversarial networks. J. Am. Med. Inform. Assoc. 26(3), 228–241 (2019)

    Article  Google Scholar 

  14. S. Hamid, The opportunities and risks of artificial intelligence in medicine and healthcare. CUSPE Commun. (2016).

  15. FDA. FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems. (2018).

  16. C. Bocchi, G. Olivi, Regulating artificial intelligence in the EU: top 10 issues for businesses to consider. (2021).

  17. D.B. Neill, Using artificial intelligence to improve hospital inpatient care. IEEE Intell. Syst. 28, 92–95 (2013)

    Article  Google Scholar 

  18. M. Fernandes, S.M. Vieira, F. Leite, C. Palos, S. Finkelstein, J.M.C. Sousa, Clinical decision support systems for triage in the emergency department using intelligent systems: a review. Artif. Intell. Med. 102, 101762 (2020)

    Article  Google Scholar 

  19. F. Gama, D. Tyskbo, J. Nygren, J. Barlow, J. Reed, P. Svedberg, Implementation Frameworks for Artificial Intelligence Translation Into Health Care Practice: Scoping Review. J Med Internet Res. 24(1), e32215 (2022)

    Article  Google Scholar 

  20. J. Wolff, J. Pauling, A. Keck, J. Baumbach, The economic impact of artificial intelligence in health care: systematic review. J Med. Internet Res. 22(2), e16866 (2020)

    Article  Google Scholar 

  21. J.E. Reed, C. Howe, C. Doyle, D. Bell, Simple rules for evidence translation in complex systems: a qualitative study. BMC Med. 16(1), 92 (2018)

    Article  Google Scholar 

  22. H. Alami, P. Lehoux, J.-L. Denis, A. Motulsky, C. Petitgand, M. Savoldelli et al., Organizational readiness for artificial intelligence in health care: insights for decision-making and practice. J Health Organ Manag. 35(1), 106–114 (2021)

    Article  Google Scholar 

  23. L. Denti, S. Hemlin, Leadership and innovation in organizations: a systematic review of factors that mediate or moderate the relationship. Int J Innov Manag. 16(03), 1240007 (2012)

    Article  Google Scholar 

  24. L.J. Damschroder, D.C. Aron, R.E. Keith, S.R. Kirsh, J.A. Alexander, J.C.J.I.S. Lowery, Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement. Sci. (2009). https://doi.org/10.1186/1748-5908-4-50

    Article  Google Scholar 

  25. T. Davenport, R. Kalakota, The potential for artificial intelligence in healthcare. Future Healthc. J. 6(2), 94–98 (2019)

    Article  Google Scholar 

  26. T. Hagendorff, The ethics of AI ethics: an evaluation of guidelines. Mind. Mach. 30, 99–120 (2020)

    Article  Google Scholar 

  27. M. Anderson, S.L. Anderson, How should AI be developed, validated, and implemented in patient care? AMA J. Ethics 21, 125–130 (2019)

    Article  Google Scholar 

  28. D. Schönberger, Artificial intelligence in healthcare: a critical analysis of the legal and ethical implications. Int. J. Law Inf. Technol. 27, 171–203 (2019)

    Google Scholar 

  29. C. Cath, Governing artificial intelligence: ethical, legal and technical opportunities and challenges. Philos. Trans. R. Soc. A 376, 20180080 (2018)

    Article  Google Scholar 

  30. M.J. Rigby, Ethical dimensions of using artificial intelligence in health care. AMA J. Ethics 21, 121–124 (2019)

    Article  Google Scholar 

  31. A.D. Thierer, A. Castillo O’Sullivan, R. Russell, Artificial intelligence and public policy. Mercatus Res. Pap. (2017). https://doi.org/10.2139/ssrn.3021135

    Article  Google Scholar 

  32. D. Wiljer, Z. Hakim, Developing an artificial intelligence–enabled health care practice: rewiring health care professions for better care. J.Med. Imaging Radiat. Sci. 50, S8–S14 (2019)

    Article  Google Scholar 

  33. S.K. Kang, C.I. Lee, P.V. Pandharipande, P.C. Sanelli, M.P. Recht, Residents’ introduction to comparative effectiveness research and big data analytics. J. Am. Coll. Radiol. 14, 534–536 (2017)

    Article  Google Scholar 

  34. L.G. McCoy, S. Nagaraj, F. Morgado, V. Harish, S. Das, L.A. Celi, What do medical students actually need to know about artificial intelligence? NPJ Digit. Med. 3, 1–3 (2020)

    Article  Google Scholar 

  35. K. Paranjape, M. Schinkel, R.N. Panday, J. Car, P. Nanayakkara, Introducing artificial intelligence training in medical education. JMIR Med. Educ. 5, e16048 (2019)

    Article  Google Scholar 

  36. R. Charow, T. Jeyakumar, S. Younus, E. Dolatabadi, M. Salhia, D. Al-Mouaswas et al., Artificial intelligence education programs for health care professionals: scoping review. JMIR Med. Educ. 7, e31043 (2021)

    Article  Google Scholar 

  37. M. Van Hartskamp, S. Consoli, W. Verhaegh, M. Petkovic, A. Van de Stolpe, Artificial intelligence in clinical health care applications. Interact. J. med. Res. 8, e12100 (2019)

    Article  Google Scholar 

  38. L.M. McShane, M.M. Cavenagh, T.G. Lively, D.A. Eberhard, W.L. Bigbee, P.M. Williams et al., Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration. BMC Med. 11, 1–22 (2013)

    Article  Google Scholar 

  39. J. He, S.L. Baxter, J. Xu, J. Xu, X. Zhou, K. Zhang, The practical implementation of artificial intelligence technologies in medicine. Nat. Med. 25, 30–36 (2019)

    Article  CAS  Google Scholar 

  40. D. Sussillo, O. Barak, Opening the black box: low-dimensional dynamics in high-dimensional recurrent neural networks. Neural Comput. 25, 626–649 (2013)

    Article  Google Scholar 

  41. L. Zhu, K. Ikeda, S. Pang, T. Ban, A. Sarrafzadeh, Merging weighted SVMs for parallel incremental learning. Neural Netw. 100, 25–38 (2018)

    Article  Google Scholar 

  42. T.T. Lee, A.S. Kesselheim, US food and drug administration precertification pilot program for digital health software: weighing the benefits and risks. Ann. Intern. Med. 168, 730–732 (2018)

    Article  Google Scholar 

  43. A. Esteva, A. Robicquet, B. Ramsundar, V. Kuleshov, M. DePristo, K. Chou et al., A guide to deep learning in healthcare. Nat. Med. 25, 24–29 (2019)

    Article  CAS  Google Scholar 

  44. Z. Ghahramani, Probabilistic machine learning and artificial intelligence. Nature 521, 452–459 (2015)

    Article  CAS  Google Scholar 

  45. Y. LeCun, Y. Bengio, G. Hinton, Deep learning. Nature 521(7553), 436–444 (2015)

    Article  CAS  Google Scholar 

  46. F. Jiang, Y. Jiang, H. Zhi, Y. Dong, H. Li, S. Ma et al., Artificial intelligence in healthcare: past, present and future. Stroke Vasc. Neurol. (2017). https://doi.org/10.1136/svn-2017-000101

    Article  Google Scholar 

  47. K. Zarringhalam, A. Enayetallah, P. Reddy, D. Ziemek, Robust clinical outcome prediction based on Bayesian analysis of transcriptional profiles and prior causal networks. Bioinformatics 30, i69–i77 (2014)

    Article  CAS  Google Scholar 

  48. W. Verhaegh, H. van Ooijen, M.A. Inda, P. Hatzis, R. Versteeg, M. Smid et al., Selection of personalized patient therapy through the use of knowledge-based computational models that identify tumor-driving signal transduction pathwayscomputational models to identify tumor-driving pathways. Can. Res. 74, 2936–2945 (2014)

    Article  CAS  Google Scholar 

  49. H. Van Ooijen, M. Hornsveld, C. Dam-de Veen, R. Velter, M. Dou, W. Verhaegh et al., Assessment of functional phosphatidylinositol 3-kinase pathway activity in cancer tissue using forkhead box-O target gene expression in a knowledge-based computational model. Am. J. pathol. 188, 1956–1972 (2018)

    Article  Google Scholar 

  50. A. van de Stolpe, L. Holtzer, H. van Ooijen, M.A. de Inda, W. Verhaegh, Enabling precision medicine by unravelling disease pathophysiology: quantifying signal transduction pathway activity across cell and tissue types. Sci. Rep. 9, 1–15 (2019)

    CAS  Google Scholar 

  51. K. Zarringhalam, A. Enayetallah, A. Gutteridge, B. Sidders, D. Ziemek, Molecular causes of transcriptional response: a Bayesian prior knowledge approach. Bioinformatics 29, 3167–3173 (2013)

    Article  CAS  Google Scholar 

  52. S.K. Gupta, Use of Bayesian statistics in drug development: advantages and challenges. Int. J. Appl. Basic Med. Res. 2, 3 (2012)

    Article  Google Scholar 

  53. W. Hao, D.Y. Yeung, Towards Bayesian deep learning: a framework and some existing methods. IEEE Trans. Knowl. Data Eng. 28, 3395–3408 (2016)

    Article  Google Scholar 

  54. H. Wang, D.-Y. Yeung, Towards Bayesian deep learning: a framework and some existing methods. IEEE Trans. Knowl. Data Eng. 28, 3395–3408 (2016)

    Article  Google Scholar 

  55. A. van de Stolpe, R.H. Kauffmann, Innovative human-specific investigational approaches to autoimmune disease. RSC Adv. 5, 18451–18463 (2015)

    Article  Google Scholar 

  56. B. Khan, S. Kumar, N. Sanbhal et al., synthesis and characterization of cyclodextrin-based scaffold incorporating ciprofloxacin antibacterial agent for skin infection prevention. Biomed. Mater. Devices (2022). https://doi.org/10.1007/s44174-022-00014-3

    Article  Google Scholar 

  57. B. Khan et al., Synthesis of Mg/AL layer double hydro—oxide and silver nano -particle based green nanocomposite for drug delivery applications. (2022).

  58. B. Khan, S. Kumar, Implementation of triply periodic minimal surface (TPMS) structure in mesenchymal stem cell differentiation. Res. Sq. (2022). https://doi.org/10.21203/rs.3.rs-2156625/v1

    Article  Google Scholar 

  59. E.O. Pyzer-Knapp, J.W. Pitera, P.W.J. Staar et al., Accelerating materials discovery using artificial intelligence, high performance computing and robotics. npj Comput. Mater. (2022). https://doi.org/10.1038/s41524-022-00765-z

    Article  Google Scholar 

  60. D. Miley, L.B. Machado, C. Condo, A.E. Jergens, K.-J. Yoon, S. Pandey, Video capsule endoscopy and ingestible electronics: emerging trends in sensors, circuits, materials, telemetry, optics, and rapid reading software. Adv. Devices Instrum. 2021, 1–30 (2021). https://doi.org/10.3433/2021/9854040

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to thanks Health @ InnoHK (Hong Kong Centre for Cerebro-Cardiovascular Health Engineering (COCHE), Shatin, Hong Kong, SAR China, Mälardalen University Sweden, and Mehran University of Engineering and Technology Jamshoro, Pakistan, for providing conductive work environment in documentation of the data.

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bangul khan.

Ethics declarations

Conflict of interest

Authors have no conflict of interest.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

khan, B., Fatima, H., Qureshi, A. et al. Drawbacks of Artificial Intelligence and Their Potential Solutions in the Healthcare Sector. Biomedical Materials & Devices 1, 731–738 (2023). https://doi.org/10.1007/s44174-023-00063-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1007/s44174-023-00063-2

Keywords

Profiles

  1. Bangul khan
  2. Jawad Hussain
  3. Saad Abdullah